Assessment of 4 Assays for PD-L1 Expression in NSCLC

This study compares the performance of 4 programmed cell death ligand 1 platforms, including 2 assays cleared by the US Food and Drug Administration and 2 laboratory-developed tests.

http://ift.tt/2mKVHw8